City

Boston (1)

Cairo (1)

Halifax (1)

Vancouver (1)

Condition

Stem Cell Leukemia (3)

Acute Myeloid Leukemia (1)

B-cell Adult Acute Lymphoblastic Leukemia (1)

Chronic Myelomonocytic Leukemia (1)

Minimal Residual Disease (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Children's Cancer Hospital Egypt 57357 (1)

Massachusetts General Hospital (1)

University of British Columbia (1)

Collaborator

Amgen (1)

Taiho Oncology, Inc. (1)

Intervention

blinatumomab (1)

inqovi (1)

morphine (1)

nalbuphine (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stem cell leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease Trial in Vancouver, Halifax

Terminated

B-cell Adult Acute Lymphoblastic Leukemia
+2 more

blinatumomab

Vancouver, British Columbia, Canada
+2 more

Feb 3, 2022

MDS, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia Trial in Boston (Inqovi)

Recruiting

Myelodysplastic Syndromes
+2 more

Inqovi

Boston, Massachusetts

Massachusetts General Hospital

Sep 29, 2021

Acute Myeloid Leukemia, Stem Cell Leukemia Trial in Cairo (Nalbuphine, Morphine)

Completed

Acute Myeloid Leukemia
Stem Cell Leukemia

Cairo, Egypt

CCHE

Jul 29, 2021